Upcoming Value Driving Events

Corporate Development

• ONCO 5 out licensing: Japan/ROW 2H02

• New strategic alliance: ER/MR/VITD 1H02

• Oncology/dermatology product acquisition 1H02

Select Corporate Partner Milestones

• AHP WAY248/WAY989 IND track/Ph I 4Q01/1H02 ERA923 Ph III 2H02

• GSK GW544/GW516 Ph I 1H02

• Lilly LLY929 Ph I 1H02 LLYXXX Ph I 2Q/3Q02

• TAP LGD2226 Ph I 2H02

Financial

• Positive operating profit 2002

• Capital restructuring: convertible debt 2002

?

Previous slide

Next slide

Back to first slide

View graphic version